Price $67.39 |
Market Cap
2.58B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
38.2
|
P/B
6.17
|
P/S
5.03
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
25.7
|
Op. Cash Flow
136.3K
|
FCF
2.5
|
|
Op. Margin
16.80%
|
Net Margin
14.20%
|
ROE
19.60%
|
ROI
18.50%
|
|
ROA
9.20%
|
EPS Growth
945.30%
|
Current Ratio
1.2
|
Debt/Equity
12.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $4.45 | - | - | 61.2M | Strong Buy |
| Horizon Pharma PLC (HZNP) | $28.21 | - | - | 3.5B | Strong Buy |
| Cryolife Inc (CRY) | $29.35 | - | - | 1.07B | Strong Buy |
| VIVUS, Inc. (VVUS) | $4.64 | - | - | 52.6M | Strong Buy |
| MTBC Inc (MTBC) | $4.66 | - | - | 52.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
